X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CKPT

Closed

Checkpoint Therapeutics Inc

4.26
0.00 (0.00%)
Last Update: 30 May 2025 23:00:00
Yesterday: 4.26
Day's Range: 4.26 - 4.26
Send
When Written:
 
2.25
Checkpoint Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy and targeted cancer treatments. The company's lead product candidate, CK-301, is a fully human monoclonal antibody targeting the PD-L1 protein, which is overexpressed in many types of cancer. Checkpoint Therapeutics is also developing a pipeline of small molecule targeted therapies for the treatment of solid tumors and hematologic malignancies. The company was founded in 2014 and is headquartered in New York City. Its common stock is listed on the NASDAQ exchange under the ticker symbol "CKPT."

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X